Svetlana Lucas Insider Profile
11 Followers
Svetlana Lucas, Director at Jasper Therapeutics, holds 3.00K shares in Scribe Therapeutics Inc. (Ticker: SCTX), holds 20.00K shares in Jasper Therapeutics (Ticker: JSPR), holds 6.00K shares in aTyr Pharma (Ticker: ATYR). Most recently, Svetlana Lucas Bought ― shares of Scribe Therapeutics Inc. on Jul 27, 2026 for an estimated value of $45.00K.
Svetlana Lucas's Trading History
You May Also Like
Svetlana Lucas insider profile FAQ
What is the percentage of profitable transactions made by Svetlana Lucas?
The percentage of profitable transactions made by Svetlana Lucas is 0%.
What is the average return per transaction made by Svetlana Lucas?
The average return per transaction made by Svetlana Lucas is -46.00%.
What stocks does Svetlana Lucas hold?
Svetlana Lucas holds: JSPR, ATYR, SCTX stocks.
What was Svetlana Lucas’s latest transaction?
Svetlana Lucas’s latest transaction was an Informative Buy of $45.00K.
What was Svetlana Lucas's most profitable transaction?
Svetlana Lucas’s most profitable transaction was an Informative Buy of SCTX stock on July 27, 2026. The return on the trade was -17.20%.
What is Svetlana Lucas's role in Jasper Therapeutics?
Svetlana Lucas's role in Jasper Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.